EKSO BIONICS (EKSO) Stock Statistics & Valuation Metrics

EKSO BIONICS has a market cap or net worth of $44.19M. The enterprise value is $32.30M.

EKSO BIONICS has 3,563,381 shares outstanding. The number of shares has decreased by -2.65% in one year.

EKSO BIONICS’s return on equity (ROE) is -1.30 and return on invested capital (ROIC) is -101.22%.

The current PE Ratio of EKSO BIONICS is ―. EKSO BIONICS’s PEG ratio is -0.00231.

In the last 12 months, EKSO BIONICS had revenue of 12.80M and earned -11.70M in profits. Earnings per share was -4.91.

In the last 12 months, operating cash flow was -11.80M and capital expenditures 0.00, giving a free cash flow of -11.80M billion.

EKSO BIONICS pays an annual dividend of ―, resulting in a dividend yield of ―

EKSO BIONICS upcoming earnings date is Apr 23, 2026, After Close (Confirmed).

EKSO BIONICS as a current ratio of 1.63, with Debt / Equity ratio of 29.20%

In the past 12 months, EKSO BIONICS has paid 0.00 in taxes.

EKSO BIONICS EV to EBITDA ratio is -2.29, with an EV/FCF ratio of -1.87.

EKSO BIONICS has $1.17M in cash and marketable securities with $2.64M in debt, giving a net cash position of -$1.47M billion.

Gross margin is 53.48%, with operating margin of -104.12%, and net profit margin of -91.37%.

The average price target for EKSO BIONICS is ―, which is 11.43% higher than the current price. The consensus rating is Hold